These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3807834)

  • 1. Renal osteodystrophy in patients on hemodialysis for more than 10 years.
    Piraino BM; Rault R; Dominguez JH; Puschett JB
    Miner Electrolyte Metab; 1986; 12(5-6):390-6. PubMed ID: 3807834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for renal osteodystrophy: a multivariant analysis.
    Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D
    J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B; Chen T; Puschett JB
    Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractures and vertebral bone mineral density in patients with renal osteodystrophy.
    Piraino B; Chen T; Cooperstein L; Segre G; Puschett J
    Clin Nephrol; 1988 Aug; 30(2):57-62. PubMed ID: 3180516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal osteodystrophy in diabetic patients.
    Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D
    Kidney Int; 1993 Jul; 44(1):159-64. PubMed ID: 8355457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal osteodystrophy.
    Klein KL; Maxwell MH
    Orthop Clin North Am; 1984 Oct; 15(4):687-95. PubMed ID: 6493735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal osteodystrophy in Maracaibo].
    Salgado O; García R; Delling G; Navarro J; Romero RA; Rodríguez-Iturbe B
    Invest Clin; 1992; 33(4):153-64. PubMed ID: 1303675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in-center daily hemodialysis upon mineral metabolism and bone disease in end-stage renal disease patients.
    Lugon JR; André MB; Duarte ME; Rembold SM; Cruz E
    Sao Paulo Med J; 2001 May; 119(3):105-9. PubMed ID: 11391452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB; Sherrard DJ; Alfrey AC; Ott S; Brickman AS; Miller NL; Maloney NA; Coburn JW
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal osteodystrophy in pre-dialysis patients: ethnic difference?
    Shin SK; Kim DH; Kim HS; Shin KT; Ma KA; Kim SJ; Kwak YS; Ha SK; Sherrard DJ
    Perit Dial Int; 1999; 19 Suppl 2():S402-7. PubMed ID: 10406554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does strict phosphorus control precipitate renal osteomalacia?
    Delmez JA; Fallon MD; Harter HR; Hruska KA; Slatopolsky E; Teitelbaum SL
    J Clin Endocrinol Metab; 1986 Apr; 62(4):747-52. PubMed ID: 3949954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aluminum in renal osteodystrophy].
    Zhu P; Wang GY; Yu YF; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of bone disorders in chronic renal failure and dialyzed patients.
    Tzamaloukas AH
    Med Clin North Am; 1990 Jul; 74(4):961-74. PubMed ID: 2195265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal osteodystrophy in end-stage renal failure patients in Israel.
    Boner G; Olah AJ; Weiss A; Seelenfreund MZ; Rosenfeld JB
    Isr J Med Sci; 1983 Jul; 19(7):608-13. PubMed ID: 6885344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings.
    Duarte ME; Peixoto AL; Pacheco AS; Peixoto AV; Rodriguez RD; Lugon JR; Cruz EA
    Sao Paulo Med J; 1998; 116(5):1790-7. PubMed ID: 10030103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining.
    Hodsman AB; Steer BM
    J Am Soc Nephrol; 1992 Feb; 2(8):1318-27. PubMed ID: 1378308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal osteodystrophy in asymptomatic hemodialysis patients: evidence of a sex-dependent distribution and predictive value of serum aluminum measurements.
    von Herrath D; Asmus G; Pauls A; Delling G; Schaefer K
    Am J Kidney Dis; 1986 Dec; 8(6):430-5. PubMed ID: 3812472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.